153 related articles for article (PubMed ID: 29281685)
1. Nanoparticle size and production efficiency are affected by the presence of fatty acids during albumin nanoparticle fabrication.
Luebbert CC; Clarke TM; Pointet R; Frahm GE; Tam S; Lorbetskie B; Sauvé S; Johnston MJW
PLoS One; 2017; 12(12):e0189814. PubMed ID: 29281685
[TBL] [Abstract][Full Text] [Related]
2. Determination of supplier-to-supplier and lot-to-lot variability in glycation of recombinant human serum albumin expressed in Oryza sativa.
Frahm GE; Smith DG; Kane A; Lorbetskie B; Cyr TD; Girard M; Johnston MJ
PLoS One; 2014; 9(10):e109893. PubMed ID: 25299339
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the differences in thermal stability of two recombinant human serum albumins with 1,2-dipalmitoyl-sn-glycero-3-phosphocholine liposomes by UV circular dichroism spectropolarimetry.
Frahm GE; Cyr TD; Smith DG; Walrond LD; Johnston MJ
J Phys Chem B; 2012 Apr; 116(15):4661-70. PubMed ID: 22423959
[TBL] [Abstract][Full Text] [Related]
4. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.
Langer K; Anhorn MG; Steinhauser I; Dreis S; Celebi D; Schrickel N; Faust S; Vogel V
Int J Pharm; 2008 Jan; 347(1-2):109-17. PubMed ID: 17681686
[TBL] [Abstract][Full Text] [Related]
5. The Investigation of the Subtle Structural Discrepancies between Oryza Sativa Recombinant and Plasma-Derived Human Serum Albumins to Design a Novel Nanoparticle as a Taxane Delivery System.
Fang R; He L; Wang Y; Wang L; Qian H; Yang S
Protein J; 2024 Jun; 43(3):544-558. PubMed ID: 38581543
[TBL] [Abstract][Full Text] [Related]
6. Large-scale production of functional human serum albumin from transgenic rice seeds.
He Y; Ning T; Xie T; Qiu Q; Zhang L; Sun Y; Jiang D; Fu K; Yin F; Zhang W; Shen L; Wang H; Li J; Lin Q; Sun Y; Li H; Zhu Y; Yang D
Proc Natl Acad Sci U S A; 2011 Nov; 108(47):19078-83. PubMed ID: 22042856
[TBL] [Abstract][Full Text] [Related]
7. Unfolding properties of recombinant human serum albumin products are due to bioprocessing steps.
Lang BE; Cole KD
Biotechnol Prog; 2015; 31(1):62-9. PubMed ID: 25270911
[TBL] [Abstract][Full Text] [Related]
8. Robust size control of bovine serum albumin (BSA) nanoparticles by intermittent addition of a desolvating agent and the particle formation mechanism.
Paik SY; Nguyen HH; Ryu J; Che JH; Kang TS; Lee JK; Song CW; Ko S
Food Chem; 2013 Nov; 141(2):695-701. PubMed ID: 23790836
[TBL] [Abstract][Full Text] [Related]
9. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
Ulbrich K; Michaelis M; Rothweiler F; Knobloch T; Sithisarn P; Cinatl J; Kreuter J
Int J Pharm; 2011 Mar; 406(1-2):128-34. PubMed ID: 21185364
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
[TBL] [Abstract][Full Text] [Related]
11. Human serum albumin from recombinant DNA technology: challenges and strategies.
Chen Z; He Y; Shi B; Yang D
Biochim Biophys Acta; 2013 Dec; 1830(12):5515-25. PubMed ID: 23644036
[TBL] [Abstract][Full Text] [Related]
12. Human serum albumin binding to silica nanoparticles--effect of protein fatty acid ligand.
Ang JC; Henderson MJ; Campbell RA; Lin JM; Yaron PN; Nelson A; Faunce T; White JW
Phys Chem Chem Phys; 2014 Jun; 16(21):10157-68. PubMed ID: 24595605
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical and immunochemical properties of recombinant human serum albumin from Pichia pastoris.
Ohtani W; Nawa Y; Takeshima K; Kamuro H; Kobayashi K; Ohmura T
Anal Biochem; 1998 Feb; 256(1):56-62. PubMed ID: 9466797
[TBL] [Abstract][Full Text] [Related]
14. Preparation of Bovine Serum Albumin (BSA) nanoparticles by desolvation using a membrane contactor: a new tool for large scale production.
Yedomon B; Fessi H; Charcosset C
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):398-405. PubMed ID: 23811438
[TBL] [Abstract][Full Text] [Related]
15. Generation of fatty acids from 1,2-dipalmitoyl-sn-glycero-3-phosphocholine/cardiolipin liposomes that stabilize recombinant human serum albumin.
Frahm GE; Cameron BE; Smith JC; Johnston MJ
J Liposome Res; 2013 Jun; 23(2):101-9. PubMed ID: 23294393
[TBL] [Abstract][Full Text] [Related]
16. Immunotoxicity assessment of rice-derived recombinant human serum albumin using human peripheral blood mononuclear cells.
Fu K; Cheng Q; Liu Z; Chen Z; Wang Y; Ruan H; Zhou L; Xiong J; Xiao R; Liu S; Zhang Q; Yang D
PLoS One; 2014; 9(8):e104426. PubMed ID: 25099245
[TBL] [Abstract][Full Text] [Related]
17. Desolvation process and surface characteristics of HSA-nanoparticles.
Weber C; Kreuter J; Langer K
Int J Pharm; 2000 Mar; 196(2):197-200. PubMed ID: 10699717
[TBL] [Abstract][Full Text] [Related]
18. Influence of bound dodecanoic acid on the reconstitution of albumin nanoparticles from a lyophilized state.
Luebbert CCE; Mansa R; Rahman R; Jakubek ZJ; Frahm GE; Zou S; Johnston MJW
Sci Rep; 2021 Feb; 11(1):4768. PubMed ID: 33637809
[TBL] [Abstract][Full Text] [Related]
19. Desolvation process and surface characterisation of protein nanoparticles.
Weber C; Coester C; Kreuter J; Langer K
Int J Pharm; 2000 Jan; 194(1):91-102. PubMed ID: 10601688
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin and paclitaxel co-bound lactosylated albumin nanoparticles having targetability to hepatocellular carcinoma.
Thao LQ; Lee C; Kim B; Lee S; Kim TH; Kim JO; Lee ES; Oh KT; Choi HG; Yoo SD; Youn YS
Colloids Surf B Biointerfaces; 2017 Apr; 152():183-191. PubMed ID: 28110040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
